{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:02:44Z","timestamp":1795093364533,"version":"4.10.2"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02642-7","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T07:06:56Z","timestamp":1740726416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":151,"title":["Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0\u20133: a cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Peng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Degang","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"issue":"20","key":"2642_CR1","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association. Circulation. 2023;148(20):1636\u201364.","journal-title":"Circulation"},{"issue":"2","key":"2642_CR2","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1681\/ASN.2012070718","volume":"24","author":"M Afkarian","year":"2013","unstructured":"Afkarian M, Sachs MC, Kestenbaum B, Hirsch IB, Tuttle KR, Himmelfarb J, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol JASN. 2013;24(2):302\u20138.","journal-title":"J Am Soc Nephrol JASN"},{"key":"2642_CR3","doi-asserted-by":"crossref","unstructured":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2015;385(9963):117\u201371.","DOI":"10.1016\/S0140-6736(14)61682-2"},{"issue":"1","key":"2642_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1053\/j.ajkd.2011.09.017","volume":"59","author":"DK Packham","year":"2012","unstructured":"Packham DK, Alves TP, Dwyer JP, Atkins R, de Zeeuw D, Cooper M, et al. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database. Am J Kidney Dis Off J Natl Kidney Found. 2012;59(1):75\u201383.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"18","key":"2642_CR5","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1001\/jama.2021.5469","volume":"325","author":"FB Ahmad","year":"2021","unstructured":"Ahmad FB, Anderson RN. The leading causes of death in the US for 2020. JAMA. 2021;325(18):1829\u201330.","journal-title":"JAMA"},{"issue":"21","key":"2642_CR6","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011\u20132020. JAMA. 2024;331(21):1858\u201360.","journal-title":"JAMA"},{"issue":"20","key":"2642_CR7","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148(20):1606\u201335.","journal-title":"Circulation"},{"issue":"4","key":"2642_CR8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2337\/db09-9028","volume":"58","author":"RA Defronzo","year":"2009","unstructured":"Defronzo RA. Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773\u201395.","journal-title":"Diabetes"},{"issue":"3","key":"2642_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2337\/dc08-1195","volume":"32","author":"K Faerch","year":"2009","unstructured":"Faerch K, Vaag A, Holst JJ, Hansen T, J\u00f8rgensen T, Borch-Johnsen K. Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Diabetes Care. 2009;32(3):439\u201344.","journal-title":"Diabetes Care"},{"issue":"3","key":"2642_CR10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000093632","volume":"26","author":"PA Sarafidis","year":"2006","unstructured":"Sarafidis PA, Ruilope LM. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol. 2006;26(3):232\u201344.","journal-title":"Am J Nephrol"},{"issue":"4","key":"2642_CR11","first-page":"201","volume":"47","author":"GM Reaven","year":"2005","unstructured":"Reaven GM. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med. 2005;47(4):201\u201310.","journal-title":"Panminerva Med"},{"key":"2642_CR12","doi-asserted-by":"crossref","unstructured":"Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y et al. Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci. 2022;23(2).","DOI":"10.3390\/ijms23020786"},{"key":"2642_CR13","doi-asserted-by":"publisher","first-page":"154766","DOI":"10.1016\/j.metabol.2021.154766","volume":"119","author":"MA Hill","year":"2021","unstructured":"Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metab Clin Exp. 2021;119:154766.","journal-title":"Metab Clin Exp"},{"issue":"20","key":"2642_CR14","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1161\/CIRCULATIONAHA.105.539528","volume":"112","author":"PW Wilson","year":"2005","unstructured":"Wilson PW, D\u2019Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112(20):3066\u201372.","journal-title":"Circulation"},{"issue":"5","key":"2642_CR15","doi-asserted-by":"publisher","first-page":"986","DOI":"10.47391\/JPMA.22-63","volume":"72","author":"VK Ramdas Nayak","year":"2022","unstructured":"Ramdas Nayak VK, Satheesh P, Shenoy MT, Kalra S. Triglyceride glucose (TyG) index: a surrogate biomarker of insulin resistance. JPMA J Pak Med Assoc. 2022;72(5):986\u20138.","journal-title":"JPMA J Pak Med Assoc"},{"issue":"7","key":"2642_CR16","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"2642_CR17","doi-asserted-by":"publisher","first-page":"109042","DOI":"10.1016\/j.diabres.2021.109042","volume":"180","author":"HM Park","year":"2021","unstructured":"Park HM, Lee HS, Lee YJ, Lee JH. The triglyceride-glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance. Diabetes Res Clin Pract. 2021;180:109042.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2642_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12933-024-02261-8","volume":"23","author":"C Liu","year":"2024","unstructured":"Liu C, Liang D. The association between the triglyceride-glucose index and the risk of cardiovascular disease in US population aged\u2009\u2264\u200965 years with prediabetes or diabetes: a population-based study. Cardiovasc Diabetol. 2024;23(1):168.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"2642_CR19","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1007\/s11357-023-01044-5","volume":"46","author":"SK Kunutsor","year":"2024","unstructured":"Kunutsor SK, Seidu S, Kurl S, Laukkanen JA. Baseline and usual triglyceride-glucose index and the risk of chronic kidney disease: a prospective cohort study. GeroScience. 2024;46(3):3035\u201346.","journal-title":"GeroScience"},{"issue":"7","key":"2642_CR20","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1007\/s10157-019-01729-2","volume":"23","author":"T Okamura","year":"2019","unstructured":"Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Triglyceride-glucose index is a predictor of incident chronic kidney disease: a population-based longitudinal study. Clin Exp Nephrol. 2019;23(7):948\u201355.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"2642_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12933-024-02152-y","volume":"23","author":"Q Liu","year":"2024","unstructured":"Liu Q, Zhang Y, Chen S, Xiang H, Ouyang J, Liu H, et al. Association of the triglyceride-glucose index with all-cause and cardiovascular mortality in patients with cardiometabolic syndrome: a national cohort study. Cardiovasc Diabetol. 2024;23(1):80.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2642_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2642_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12933-024-02215-0","volume":"23","author":"X Wei","year":"2024","unstructured":"Wei X, Min Y, Song G, Ye X, Liu L. Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome. Cardiovasc Diabetol. 2024;23(1):134.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2642_CR24","doi-asserted-by":"publisher","first-page":"31352","DOI":"10.1038\/s41598-024-82881-y","volume":"14","author":"L Wu","year":"2024","unstructured":"Wu L, Huang Z. Elevated triglyceride glucose index is associated with advanced cardiovascular kidney metabolic syndrome. Sci Rep. 2024;14(1):31352.","journal-title":"Sci Rep"},{"issue":"1","key":"2642_CR25","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12933-024-02352-6","volume":"23","author":"W Li","year":"2024","unstructured":"Li W, Shen C, Kong W, Zhou X, Fan H, Zhang Y, et al. Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with cardiovascular-kidney-metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024;23(1):292.","journal-title":"Cardiovasc Diabetol"},{"key":"2642_CR26","doi-asserted-by":"publisher","first-page":"160096","DOI":"10.1038\/sdata.2016.96","volume":"3","author":"CJ Patel","year":"2016","unstructured":"Patel CJ, Pho N, McDuffie M, Easton-Marks J, Kothari C, Kohane IS, et al. A database of human exposomes and phenomes from the US National Health and Nutrition Examination Survey. Sci data. 2016;3:160096.","journal-title":"Sci data"},{"key":"2642_CR27","unstructured":"htm NCfHSJHNCfHSAoahwcgnni. Centers for Disease control and prevention NCHS research ethics review board (ERB) approval. 2023."},{"issue":"6","key":"2642_CR28","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","volume":"149","author":"SS Khan","year":"2024","unstructured":"Khan SS, Matsushita K, Sang Y, Ballew SH, Grams ME, Surapaneni A, et al. Development and validation of the American Heart Association\u2019s PREVENT equations. Circulation. 2024;149(6):430\u201349.","journal-title":"Circulation"},{"key":"2642_CR29","doi-asserted-by":"crossref","unstructured":"KDIGO 2024 Clinical Practice Guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4s):S117\u2013314.","DOI":"10.1016\/j.kint.2023.10.018"},{"issue":"19","key":"2642_CR30","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737\u201349.","journal-title":"N Engl J Med"},{"issue":"4","key":"2642_CR31","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1001\/jamacardio.2018.0005","volume":"3","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM. The 2017 American College of Cardiology\/American Heart Association Clinical Practice Guideline for high blood pressure in adults. JAMA Cardiol. 2018;3(4):352\u20133.","journal-title":"JAMA Cardiol"},{"key":"2642_CR32","doi-asserted-by":"crossref","unstructured":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17\u201338.","DOI":"10.2337\/dc22-S002"},{"issue":"5","key":"2642_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/jama.2014.9440","volume":"312","author":"J Cao","year":"2014","unstructured":"Cao J, Zhang S. Multiple comparison procedures. JAMA. 2014;312(5):543\u20134.","journal-title":"JAMA"},{"issue":"7139","key":"2642_CR34","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","volume":"316","author":"TV Perneger","year":"1998","unstructured":"Perneger TV. What\u2019s wrong with Bonferroni adjustments. BMJ (Clin Res ed). 1998;316(7139):1236\u20138.","journal-title":"BMJ (Clin Res ed)"},{"issue":"1","key":"2642_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12933-024-02390-0","volume":"23","author":"S Li","year":"2024","unstructured":"Li S, An L, Fu Z, Zhang W, Liu H. Association between triglyceride-glucose related indices and all-cause and cause-specific mortality in the general population: a cohort study. Cardiovasc Diabetol. 2024;23(1):286.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2642_CR36","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/S2666-7568(22)00247-1","volume":"4","author":"P Lopez-Jaramillo","year":"2023","unstructured":"Lopez-Jaramillo P, Gomez-Arbelaez D, Martinez-Bello D, Abat MEM, Alhabib KF, Avezum \u00c1, et al. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study. Lancet Healthy Longev. 2023;4(1):e23\u201333.","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"2642_CR37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12933-024-02148-8","volume":"23","author":"G Alavi Tabatabaei","year":"2024","unstructured":"Alavi Tabatabaei G, Mohammadifard N, Rafiee H, Nouri F, Maghami Mehr A, Najafian J, et al. Association of the triglyceride glucose index with all-cause and cardiovascular mortality in a general population of Iranian adults. Cardiovasc Diabetol. 2024;23(1):66.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"2642_CR38","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.2337\/dc18-1920","volume":"42","author":"K Park","year":"2019","unstructured":"Park K, Ahn CW, Lee SB, Kang S, Nam JS, Lee BK, et al. Elevated TyG index predicts progression of coronary artery calcification. Diabetes Care. 2019;42(8):1569\u201373.","journal-title":"Diabetes Care"},{"key":"2642_CR39","doi-asserted-by":"publisher","first-page":"101135","DOI":"10.1016\/j.lanwpc.2024.101135","volume":"49","author":"G He","year":"2024","unstructured":"He G, Zhang Z, Wang C, Wang W, Bai X, He L, et al. Association of the triglyceride-glucose index with all-cause and cause-specific mortality: a population-based cohort study of 3.5 million adults in China. Lancet Reg Health Western Pac. 2024;49:101135.","journal-title":"Lancet Reg Health Western Pac"},{"issue":"1","key":"2642_CR40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12933-024-02269-0","volume":"23","author":"C Liu","year":"2024","unstructured":"Liu C, Liang D, Xiao K, Xie L. Association between the triglyceride-glucose index and all-cause and CVD mortality in the young population with diabetes. Cardiovasc Diabetol. 2024;23(1):171.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2642_CR41","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12933-024-02287-y","volume":"23","author":"Y Min","year":"2024","unstructured":"Min Y, Wei X, Wei Z, Song G, Zhao X, Lei Y. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):188.","journal-title":"Cardiovasc Diabetol"},{"key":"2642_CR42","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/s41366-023-01454-7","volume":"48","author":"J Zhou","year":"2024","unstructured":"Zhou J, Huang H, Huang H, Peng J, Chen W, Chen F et al. Association of triglyceride-glucose index and its combination with adiposity-related indices with the incidence of myocardial infarction: a cohort study from the UK Biobank. Int J Obes (2005). 2024;48(10):1498\u2013505.","journal-title":"Int J Obes (2005)"},{"issue":"3","key":"2642_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1467-789X.2011.00952.x","volume":"13","author":"M Ashwell","year":"2012","unstructured":"Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev Off J Int Assoc Study Obes. 2012;13(3):275\u201386.","journal-title":"Obes Rev Off J Int Assoc Study Obes"},{"key":"2642_CR44","doi-asserted-by":"publisher","first-page":"e57799","DOI":"10.2196\/57799","volume":"10","author":"D Yang","year":"2024","unstructured":"Yang D, Ma L, Cheng Y, Shi H, Liu Y, Shi C. Utility of anthropometric indexes for detecting metabolic syndrome in Resource-Limited regions of Northwestern China: cross-sectional study. JMIR Public Health Surveill. 2024;10:e57799.","journal-title":"JMIR Public Health Surveill"},{"key":"2642_CR45","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez-Manent JI, Jover AM, Martinez CS, Tom\u00e1s-Gil P, Mart\u00ed-Lliteras P, L\u00f3pez-Gonz\u00e1lez. \u00c1 A. Waist circumference is an essential factor in Predicting insulin resistance and early detection of metabolic syndrome in adults. Nutrients. 2023;15(2).","DOI":"10.3390\/nu15020257"},{"key":"2642_CR46","doi-asserted-by":"publisher","first-page":"1502321","DOI":"10.3389\/fendo.2024.1502321","volume":"15","author":"M Zhu","year":"2024","unstructured":"Zhu M, Wang K, Feng J, Liu Y, Guan M, Wang Y, et al. The waist-to-height ratio is a good predictor for insulin resistance in women with polycystic ovary syndrome. Front Endocrinol. 2024;15:1502321.","journal-title":"Front Endocrinol"},{"issue":"2","key":"2642_CR47","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s42000-023-00448-4","volume":"22","author":"S Yan","year":"2023","unstructured":"Yan S, Wang D, Jia Y. Comparison of insulin resistance-associated parameters in US adults: a cross-sectional study. Hormones (Athens Greece). 2023;22(2):331\u201341.","journal-title":"Hormones (Athens Greece)"},{"issue":"3","key":"2642_CR48","doi-asserted-by":"publisher","first-page":"e0212963","DOI":"10.1371\/journal.pone.0212963","volume":"14","author":"J Lim","year":"2019","unstructured":"Lim J, Kim J, Koo SH, Kwon GC. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: an analysis of the 2007\u20132010 Korean National Health and Nutrition Examination Survey. PLoS ONE. 2019;14(3):e0212963.","journal-title":"PLoS ONE"},{"issue":"16","key":"2642_CR49","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","volume":"139","author":"J Rangaswami","year":"2019","unstructured":"Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2019;139(16):e840\u201378.","journal-title":"Circulation"},{"key":"2642_CR50","doi-asserted-by":"crossref","unstructured":"Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci. 2019;20(9).","DOI":"10.3390\/ijms20092358"},{"issue":"1","key":"2642_CR51","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13098-024-01408-7","volume":"16","author":"R Shen","year":"2024","unstructured":"Shen R, Lin L, Bin Z, Qiao X. The U-shape relationship between insulin resistance-related indexes and chronic kidney disease: a retrospective cohort study from National Health and Nutrition Examination Survey 2007\u20132016. Diabetol Metab Syndr. 2024;16(1):168.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"2642_CR52","doi-asserted-by":"publisher","first-page":"13884","DOI":"10.1038\/s41598-024-63886-z","volume":"14","author":"S Xiao","year":"2024","unstructured":"Xiao S, Zhang Q, Yang HY, Tong JY, Yang RQ. The association between triglyceride glucose-body mass index and all-cause and cardiovascular mortality in diabetes patients: a retrospective study from NHANES database. Sci Rep. 2024;14(1):13884.","journal-title":"Sci Rep"},{"key":"2642_CR53","doi-asserted-by":"publisher","first-page":"1863429","DOI":"10.1155\/2022\/1863429","volume":"2022","author":"J Pei","year":"2022","unstructured":"Pei J, Wang B, Wang D. Current studies on molecular mechanisms of insulin resistance. J Diabetes Res. 2022;2022:1863429.","journal-title":"J Diabetes Res"},{"issue":"1","key":"2642_CR54","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s10020-024-01019-y","volume":"30","author":"MS Islam","year":"2024","unstructured":"Islam MS, Wei P, Suzauddula M, Nime I, Feroz F, Acharjee M, et al. The interplay of factors in metabolic syndrome: understanding its roots and complexity. Mol Med (Cambridge Mass). 2024;30(1):279.","journal-title":"Mol Med (Cambridge Mass)"},{"issue":"1","key":"2642_CR55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41574-024-01047-y","volume":"21","author":"M Sot\u00e1k","year":"2025","unstructured":"Sot\u00e1k M, Clark M, Suur BE, B\u00f6rgeson E. Inflammation and resolution in obesity. Nat Rev Endocrinol. 2025;21(1):45\u201361.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"2642_CR56","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2337\/db16-1167","volume":"66","author":"A Gastaldelli","year":"2017","unstructured":"Gastaldelli A, Gaggini M, DeFronzo RA. Role of adipose tissue insulin resistance in the natural history of type 2 diabetes: results from the San Antonio Metabolism Study. Diabetes. 2017;66(4):815\u201322.","journal-title":"Diabetes"},{"issue":"6","key":"2642_CR57","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrcardio.2009.55","volume":"6","author":"VZ Rocha","year":"2009","unstructured":"Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol. 2009;6(6):399\u2013409.","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"2642_CR58","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1210\/jc.2004-0518","volume":"89","author":"BJ Goldstein","year":"2004","unstructured":"Goldstein BJ, Scalia R, Adiponectin. A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab. 2004;89(6):2563\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2642_CR59","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12933-025-02595-x","volume":"24","author":"W Ni","year":"2025","unstructured":"Ni W, Jiang R, Xu D, Zhu J, Chen J, Lin Y, et al. Association between insulin resistance indices and outcomes in patients with heart failure with preserved ejection fraction. Cardiovasc Diabetol. 2025;24(1):32.","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"2642_CR60","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.2337\/dc24-0475","volume":"47","author":"R Sun","year":"2024","unstructured":"Sun R, Wang J, Li M, Li J, Pan Y, Liu B, et al. Association of insulin resistance with cardiovascular disease and all-cause mortality in type 1 diabetes: systematic review and meta-analysis. Diabetes Care. 2024;47(12):2266\u201374.","journal-title":"Diabetes Care"},{"issue":"1","key":"2642_CR61","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s12916-024-03582-x","volume":"22","author":"J Peng","year":"2024","unstructured":"Peng J, Zhang Y, Zhu Y, Chen W, Chen L, Ma F, et al. Estimated glucose disposal rate for predicting cardiovascular events and mortality in patients with non-diabetic chronic kidney disease: a prospective cohort study. BMC Med. 2024;22(1):411.","journal-title":"BMC Med"},{"issue":"4","key":"2642_CR62","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/oxfordjournals.aje.a010013","volume":"150","author":"R Clarke","year":"1999","unstructured":"Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150(4):341\u201353.","journal-title":"Am J Epidemiol"},{"key":"2642_CR63","first-page":"200428","volume":"23","author":"G Dharmarathne","year":"2024","unstructured":"Dharmarathne G, Bogahawaththa M, Rathnayake U, Meddage DPP. Integrating explainable machine learning and user-centric model for diagnosing cardiovascular disease: a novel approach. Intell Syst Appl. 2024;23:200428.","journal-title":"Intell Syst Appl"},{"key":"2642_CR64","first-page":"200397","volume":"22","author":"G Dharmarathne","year":"2024","unstructured":"Dharmarathne G, Bogahawaththa M, McAfee M, Rathnayake U, Meddage DPP. On the diagnosis of chronic kidney disease using a machine learning-based interface with explainable artificial intelligence. Intell Syst Appl. 2024;22:200397.","journal-title":"Intell Syst Appl"},{"key":"2642_CR65","doi-asserted-by":"publisher","first-page":"100301","DOI":"10.1016\/j.health.2024.100301","volume":"5","author":"G Dharmarathne","year":"2024","unstructured":"Dharmarathne G, Jayasinghe TN, Bogahawaththa M, Meddage DPP, Rathnayake U. A novel machine learning approach for diagnosing diabetes with a self-explainable interface. Healthc Anal. 2024;5:100301.","journal-title":"Healthc Anal"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02642-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02642-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02642-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T07:09:00Z","timestamp":1740726540000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02642-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2642"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02642-7","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The NHANES study protocol received approval from the Ethics Review Board of the National Center for Health Statistics. All participants executed a written informed consent form before their involvement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}